摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(cyclopropyl)methanone | 64579-61-9

中文名称
——
中文别名
——
英文名称
(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(cyclopropyl)methanone
英文别名
1-(4-amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclopropanecarbonyl-piperazine;4-amino-2-[4-(cyclopropylcarbonyl)-1-piperazinyl]-6,7-dimethoxyquinazoline;[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-cyclopropylmethanone
(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(cyclopropyl)methanone化学式
CAS
64579-61-9
化学式
C18H23N5O3
mdl
——
分子量
357.412
InChiKey
PQAOBJDQAFJTBT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    631.4±65.0 °C(Predicted)
  • 密度:
    1.353±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    93.8
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-哌嗪基-4-氨基-6,7-二甲氧基喹唑啉环丙甲酸N,N-二异丙基乙胺2-肟氰乙酸乙酯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以59%的产率得到(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(cyclopropyl)methanone
    参考文献:
    名称:
    Targeting Influenza A Virus RNA Promoter
    摘要:
    The emergence of drug‐resistant strains of influenza virus makes exploring new classes of inhibitors that target universally conserved viral targets a highly important goal. The influenza A viral genome is made up of eight single‐stranded RNA‐negative segments. The RNA promoter, consisting of the conserved sequences at the 3′ and 5′ end of each RNA genomic segment, is universally conserved among influenza A virus strains and in all segments. Previously, we reported on the identification and NMR structure of DPQ (6,7‐dimethoxy‐2‐(1‐piperazinyl)‐4‐quinazolinamine) (compound 1) in complex with the RNA promoter. Here, we report on additional screening and SAR studies with compound 1, including ex vivo anti‐influenza activity assays, resulted in improved cellular activity against influenza A virus in the micromolar range.
    DOI:
    10.1111/cbdd.12534
点击查看最新优质反应信息

文献信息

  • Method of treating a patient having precancerous lesions with quinazoline derivatives
    申请人:Cell Pathways, Inc.
    公开号:US06262059B1
    公开(公告)日:2001-07-17
    Derivatives of Quinazoline are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.
    喹唑啉衍生物对于治疗患有癌前病变的患者很有用。这些化合物还可用于抑制肿瘤细胞的生长。
  • 2-Piperazinyl-6,7-dimethoxyquinazolines
    申请人:Mead Johnson & Company
    公开号:US04060615A1
    公开(公告)日:1977-11-29
    A series of novel 4-amino or 4-hydrazino-2-(substituted piperazinyl)-6,7-dimethoxyquinazolines is disclosed having antihypertensive and phosphodiesterase inhibiting properties. Piperazinyl substituents include cycloalkenylcarbonyl, cycloalkylcarbonyl, and methylcycloalkylcarbonyl. A representative embodiment of the invention is 4-amino-2-[4-(cyclopentylcarbonyl)-1-piperazinyl]-6,7-dimethoxyquinazoline .
    一系列新颖的4-氨基或4-联氨基-2-(取代哌嗪基)-6,7-二甲氧基喹唑啉类化合物被披露,具有降压和磷酸二酯酶抑制特性。哌嗪基取代物包括环烯基羰基、环烷基羰基和甲基环烷基羰基。该发明的代表性实施例是4-氨基-2-[4-(环戊基羰基)-1-哌嗪基]-6,7-二甲氧基喹唑啉。
  • US4060615A
    申请人:——
    公开号:US4060615A
    公开(公告)日:1977-11-29
  • US6262059B1
    申请人:——
    公开号:US6262059B1
    公开(公告)日:2001-07-17
  • Targeting Influenza A Virus RNA Promoter
    作者:Angel Bottini、Surya K. De、Bainan Wu、Changyan Tang、Gabriele Varani、Maurizio Pellecchia
    DOI:10.1111/cbdd.12534
    日期:2015.10
    The emergence of drug‐resistant strains of influenza virus makes exploring new classes of inhibitors that target universally conserved viral targets a highly important goal. The influenza A viral genome is made up of eight single‐stranded RNA‐negative segments. The RNA promoter, consisting of the conserved sequences at the 3′ and 5′ end of each RNA genomic segment, is universally conserved among influenza A virus strains and in all segments. Previously, we reported on the identification and NMR structure of DPQ (6,7‐dimethoxy‐2‐(1‐piperazinyl)‐4‐quinazolinamine) (compound 1) in complex with the RNA promoter. Here, we report on additional screening and SAR studies with compound 1, including ex vivo anti‐influenza activity assays, resulted in improved cellular activity against influenza A virus in the micromolar range.
查看更多